Moatly / Stocks / BMRN

Biomarin Pharmaceutical Inc (BMRN) — what is it worth?

$57.13 · $11.1B market cap · Biotechnology
Scored from reported financial statements. Data as of 2026-11-11.
Moat
84
Durability of advantage
Management
60
Returns and capital use
Margin of safety
0
Price against value
Buy price
$41.48
Consensus of three methods
Intrinsic value
N/A
What the business is worth
Margin of safety price
N/A
Intrinsic value less 50%
10-CAP price
$30.66
Ten times owner earnings
Payback time price
$41.48
Eight years of free cash flow

Key figures

Price$57.13
Market cap$11.1B
P/E ratioN/A
Return on invested capital5.6%
Gross margin77.1%
Debt to equity0.11x
Free cash flow yield6.4%
Growth rate used11.6%
Growth rate measured12.0%
Exit multiple assumed23.2x

How it compares

CompanyMoatBuy price
Bio-Techne (TECH)50$17.73
Halozyme Therapeutics Inc (HALO)73$105.48
Jazz Pharmaceuticals Plc (JAZZ)53$321.05
Incyte (INCY)88$140.62

Be in the know

Subscribe to our Substack for deeper insights on value plays.

Subscribe free

Run your own assumptions

Every number above is built on assumptions that can be changed. In Moatly you can move the growth rate, the exit multiple and the margin of safety and watch every figure recalculate, so you are testing your own view of Biomarin Pharmaceutical Inc rather than accepting ours.

Download on the App StoreGet it on Google Play

Not investment advice. Estimates only, built on stated assumptions that could be wrong. Figures are drawn from reported financial statements and were current as of the date shown. Do your own research.